(VIANEWS) – Shares of 10x Genomics (NASDAQ Composite: TXG) dropped 5.59% to $133.41 at 14:29 EST on Wednesday, after five consecutive sessions in a row of losses. NASDAQ Composite is sliding 1.53% to $15,383.54, following the last session’s downward trend. This seems, as yet, an all-around negative trend trading session today.

10x Genomics’s last close was $141.31, 32.38% under its 52-week high of $208.99.


Today’s last reported volume for 10x Genomics is 269108 which is 60.51% below its average volume of 681509.

10x Genomics’s Sales

10x Genomics’s sales growth is 78.1% for the ongoing quarter and 33.2% for the next. The company’s growth estimates for the current quarter and the next is 70.8% and 97.2%, respectively.

10x Genomics’s Revenue

Year-on-year quarterly revenue growth grew by 170%, now sitting on 405.7M for the twelve trailing months.


10x Genomics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.66%, a positive 0.51%, and a positive 2.76%, respectively.

10x Genomics’s highest amplitude of average volatility was 2.55% (last week), 2.69% (last month), and 2.76% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

10x Genomics’s stock is considered to be overbought (>=80).

10x Genomics’s Stock Yearly Top and Bottom Value

10x Genomics’s stock is valued at $133.41 at 14:29 EST, way under its 52-week high of $208.99 and higher than its 52-week low of $128.15.

10x Genomics’s Moving Average

10x Genomics’s worth is way below its 50-day moving average of $155.93 and way under its 200-day moving average of $170.12.

More news about 10x Genomics (TXG).


Please enter your comment!
Please enter your name here